Ranjan, D., A. Sharma, and R. B. Bodla. “Saxagliptin and Dapagliflozin for Type 2 Diabetes Mellitus: A Review”. International Journal of Drug Regulatory Affairs, Vol. 6, no. 3, Sept. 2018, pp. 24-30, doi:10.22270/ijdra.v6i3.264.